Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design. Romaguera R, Salinas P, Brugaletta S, Gomez-Lara J, et al. Am Heart J 2020;222:174-182.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Romaguera R, Salinas P, Brugaletta S, Gomez-Lara J, et al. Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design. Am Heart J 2020;222:174-182.
PMID: 32087418